Skip to content

Acupuncture Therapy for Hand-Foot Syndrome in Patients with Abdominal and Pelvic Tumors After Targeted Therapy: A Randomized Controlled Trial (RCT)

Acupuncture Therapy for Hand-Foot Syndrome in Patients with Abdominal and Pelvic Tumors After Targeted Therapy: A Randomized Controlled Trial (RCT)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000500
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand-Foot Syndrome in Abdominopelvic Tumor Patients After Targeted Therapy

Interventions

Control Group:Single-targeted therapy
Treatment group:Targeted therapy plus cheek acupuncture therapy group

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-75 years old; 2) Abdominal and pelvic malignant tumors with indications for targeted therapy; 3) Expected survival >12 months; 4) ECOG performance status 0-1; 5) Child-Pugh liver function score 5-7 points; 6) Blood, liver, and kidney function meet the following criteria: a) Neutrophil count =1.5×10^9/L b) Platelet count =75×10^9/L c) Hemoglobin concentration =90g/L d) Serum albumin concentration =30g/L e) Total bilirubin =50umol/L f) AST, ALT <5 times the upper limit of normal, ALP <4 times the upper limit of normal g) International normalized ratio =2.3 h) Creatinine <1.5 times the upper limit of normal 7) Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1) Concurrent with other malignant tumors or having other malignant tumors within 5 years prior to enrollment; 2) Facial skin surface ulceration or infection; 3) History of local hand-foot skin diseases, such as tinea pedis or hyperkeratosis, prior to treatment; 4) Subjects currently receiving other treatments that may cause skin toxicity; 5) Subjects currently receiving other medications for hand-foot syndrome, such as COX-2 enzyme inhibitors; 6) Refusal to undergo cheek acupuncture treatment; 7) Severe heart, kidney, or other organ dysfunction, such as arrhythmia (requiring anti-arrhythmic medications or pacemaker implantation), uncontrolled hypertension, history of myocardial infarction within 6 months, QT interval prolongation >450 ms, or congestive heart failure >NYHA class 2; 8) Pregnant, breastfeeding women, or subjects planning pregnancy within the next two years; 9) Other severe conditions, such as alcoholism, drug abuse, or mental/psychiatric disorders, which may affect informed consent or compliance.

Design outcomes

Primary

MeasureTime frame
Hand-Foot Syndrome Grading Evaluation;Skin Health Score;Quality of Life Rating;Fatigue Rating;

Countries

China

Contacts

Public ContactZhang Shijun

The First Affiliated Hospital of Sun Yat-sen University

zhshjun@mail.sysu.edu.cn13925080191

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026